⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4598725 | 0.85 | — | — | |
| SCHEMBL18587669 | 0.81 | — | — | |
| SCHEMBL28912442 | 0.67 | — | — | |
| SCHEMBL17307519 | 0.67 | — | — | |
| SCHEMBL16962034 | 0.67 | — | — | |
| SCHEMBL17629746 | 0.65 | — | — | |
| SCHEMBL9376005 | 0.62 | — | — | |
| SCHEMBL11911535 | 0.62 | — | — | |
| SCHEMBL17629784 | 0.60 | — | — | |
| SCHEMBL19622238 | 0.60 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180250280-A1 | SUBSTITUTED OXOPYRIDINE DERIVATIVES | BAYER PHARMA AKTIENGESELLSCHAFT (DE) | 2018-09-06 | — | — | US | disclosed |
| EP-3344618-A1 | SUBSTITUTED OXOPYRIDINE DERIVATIVES | Bayer Pharma Aktiengesellschaft (DE) | 2018-07-11 | — | — | EP | disclosed |
| WO-2017037051-A1 | SUBSTITUTED OXOPYRIDINE DERIVATIVES | BAYER PHARMA AKTIENGESELLSCHAFT (DE) | 2017-03-09 | — | — | WO | disclosed |